Compile Data Set for Download or QSAR
Report error Found 29 Enz. Inhib. hit(s) with all data for entry = 12763
TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726378(US12247015, Example 16)
Affinity DataKd:  31.6nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726377(US12247015, Example 12)
Affinity DataKd:  35.5nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726376(US12247015, Example 7)
Affinity DataKd:  53.7nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726385(US12247015, Example 66)
Affinity DataKd:  60.3nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726384(US12247015, Example 65)
Affinity DataKd:  88.1nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726382(US12247015, Example 39)
Affinity DataKd:  88.1nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726379(US12247015, Example 28)
Affinity DataKd:  93.3nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726380(US12247015, Example 34)
Affinity DataKd:  94.4nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726372(US12247015, Example 2)
Affinity DataKd:  104nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726374(US12247015, Example 4)
Affinity DataKd:  106nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726375(US12247015, Example 6)
Affinity DataKd:  166nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726388(US12247015, Example 103)
Affinity DataKd:  176nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726371(US12247015, Example 1)
Affinity DataKd:  189nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726393(US12247015, Example 116)
Affinity DataKd:  207nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726397(US12247015, Example 147)
Affinity DataKd:  214nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726373(US12247015, Example 3)
Affinity DataKd:  263nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726391(US12247015, Example 109)
Affinity DataKd:  266nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726394(US12247015, Example 125)
Affinity DataKd:  285nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726396(US12247015, Example 137)
Affinity DataKd:  288nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726395(US12247015, Example 136)
Affinity DataKd:  292nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726390(US12247015, Example 107)
Affinity DataKd:  302nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726398(US12247015, Example 162)
Affinity DataKd:  309nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726383(US12247015, Example 43)
Affinity DataKd:  339nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726386(US12247015, Example 89)
Affinity DataKd:  447nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726387(US12247015, Example 102)
Affinity DataKd:  525nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726392(US12247015, Example 114)
Affinity DataKd:  804nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726389(US12247015, Example 105)
Affinity DataKd:  871nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726399(US12247015, Example 169)
Affinity DataKd:  1.12E+3nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent

TargetMas-related G-protein coupled receptor member X2(Human)
Solent Therapeutics

US Patent
LigandPNGBDBM726381(US12247015, Example 35)
Affinity DataKd:  2.00E+4nMAssay Description:Equilibrium dissociation constants, Kd, for many of the compounds described in the Examples section (“test compounds”) are determined in the presence...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/15/2025
Entry Details
US Patent